Nebraska Health System — Omaha, Nebraska

Nebraska Health System is a clinical research site located in Omaha, Nebraska, United States 68105-1018.

Crixeo Clinical Trials Trust Score: 24/100 (FAILING). This profile has not yet been claimed by the site owner.

Nebraska Health System has participated in 29 clinical trials.

Therapeutic areas: Lung Cancer, Prostate Cancer, Stage III Adult Soft Tissue Sarcoma.

Sponsors: Radiation Therapy Oncology Group, National Institute of Allergy and Infectious Diseases (NIAID).

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Omaha

Browse all research sites in Nebraska · View every site in Omaha

Sponsor Feasibility Report

Trust Score: 24/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Nebraska Health System?

Nebraska Health System has a Crixeo Trust Score of 24/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Nebraska Health System conducted?

Nebraska Health System has 29 clinical trials on record. Their work covers Lung Cancer, Prostate Cancer, Stage III Adult Soft Tissue Sarcoma.

Is Nebraska Health System accredited by Crixeo Clinical Trials?

Nebraska Health System has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Nebraska Health System?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.